المؤلفون: Azoulay, Elie, Bauer, Philippe R., Mariotte, Eric, Russell, Lene, Knoebl, Paul, Martin-Loeches, Ignacio, Pène, Frédéric, Puxty, Kathryn, Povoa, Pedro, Barratt-Due, Andreas, Garnacho-Montero, Jose, Wendon, Julia, Munshi, Laveena, Benoit, Dominique, von Bergwelt-Baildon, Michael, Maggiorini, Marco, Coppo, Paul, Cataland, Spero, Veyradier, Agnès, Van de Louw, Andry

المصدر: Intensive Care Medicine; Nov2019, Vol. 45 Issue 11, p1518-1539, 22p, 1 Color Photograph, 1 Diagram, 9 Charts, 1 Graph

مصطلحات موضوعية: THROMBOTIC thrombocytopenic purpura, CRITICALLY ill, THROMBOTIC thrombocytopenic purpura treatment, ADRENOCORTICAL hormones, HEALTH status indicators, INTENSIVE care units, PLASMA exchange (Therapeutics), DISEASE management

المؤلفون: Cataland, Spero R.¹ spero.cataland@osumc.edu, Wu, Haifeng M.² haifeng.wu@osumc.edu

المصدر: European Journal of Internal Medicine. Sep2013, Vol. 24 Issue 6, p486-491. 6p.

مصطلحات موضوعية: *HEMOLYTIC-uremic syndrome treatment, *THROMBOTIC thrombocytopenic purpura treatment, *PATHOLOGICAL physiology, *PLASMA exchange (Therapeutics), *COMPLEMENT inhibition, *TREATMENT effectiveness

المؤلفون: Yui, Jennifer, Holers, V. Michael, Yang, Shangbin, Wu, Haifeng M., Cataland, Spero R.

المصدر: British Journal of Haematology; Dec2014, Vol. 167 Issue 5, p697-698, 2p, 2 Charts

مصطلحات موضوعية: BIOMARKERS, THERAPEUTIC use of biochemical markers, THROMBOTIC microangiopathies, THROMBOTIC thrombocytopenic purpura treatment, PATIENTS, DIAGNOSIS

المؤلفون: Cataland, Spero R.¹

المصدر: Blood. 8/18/2011, Vol. 118 Issue 7, p1711-1712. 1p.

مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura treatment, *RITUXIMAB, *DISEASE relapse, *PLASMA exchange (Therapeutics), *CLINICAL trials

المؤلفون: Scully, M.¹, Cataland, S. R.², Peyvandi, F.³, Coppo, P.⁴, Knöbl, P.⁵, Hovinga, J. A. Kremer⁶, Metjian, A.⁷, de la Rubia, J.⁸, Pavenski, K.⁹, Callewaert, F.¹⁰, Biswas, D.¹⁰, De Winter, H.¹⁰, Zeldin, R. K.¹⁰ hilde.dewinter@ablynx.com, Scully, Marie¹¹, Cataland, Spero R¹¹, Peyvandi, Flora¹¹, Coppo, Paul¹¹, Knöbl, Paul¹¹, Kremer Hovinga, Johanna A¹¹, Metjian, Ara¹¹

المصدر: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.

مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GINGIVAL hyperplasia, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *PLASMA exchange (Therapeutics), *RESEARCH, *THROMBOTIC thrombocytopenic purpura, *EVALUATION research, *BODY mass index, *RANDOMIZED controlled trials, *BLIND experiment, *PLATELET count, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents

المؤلفون: Peyvandi, Flora^1,2, Scully, Marie^3,4, Hovinga, Johanna A. Kremer^5,6, Cataland, Spero⁷, Knöbl, Paul⁸, Haifeng Wu⁹, Artoni, Andrea¹, Westwood, John-Paul³, Taleghani, Magnus Mansouri^5,6, Jilma, Bernd¹⁰, Callewaert, Filip¹¹ filip.callewaert@ablynx.com, Ulrichts, Hans¹², Duby, Christian¹¹, Tersago, Dominique¹¹, Kremer Hovinga, Johanna A (AUTHOR), Wu, Haifeng (AUTHOR), Mansouri Taleghani, Magnus (AUTHOR), TITAN Investigators (CORPORATE AUTHOR)

المصدر: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.

مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *BLOOD platelet aggregation, *PLASMA exchange (Therapeutics), *TREATMENT effectiveness, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GLYCOPROTEINS, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESEARCH funding, *THROMBOTIC thrombocytopenic purpura, *DISEASE relapse, *EVALUATION research, *RANDOMIZED controlled trials, *DISEASE remission, *BLIND experiment, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents